Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 20564-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#20564-1-AP, RRID:AB_10693534
- Product name
- PAFAH1B3 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated PAFAH1B3 antibody (Cat. #20564-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references PAFAH1B3 Exists in Linear Chromosomal and Extrachromosomal Circular DNA and Promotes HCC Progression via EMT.
Prognostic clinical phenotypes associated with tumor stemness in the immune microenvironment of T-cell exhaustion for hepatocellular carcinoma.
Increased PAFAH1B3 was associated with poor prognosis and T-cell exhaustion microenvironment in hepatocellular carcinoma.
Aberrant expression of PAFAH1B3 associates with poor prognosis and affects proliferation and aggressiveness in hypopharyngeal squamous cell carcinoma.
Li D, Sun H, Wang Y, Yin Y, Zhu Y, Qian X, Wang S, Zhang L, Zhao H, Qiu L
International journal of molecular sciences 2025 Sep 10;26(18)
International journal of molecular sciences 2025 Sep 10;26(18)
Prognostic clinical phenotypes associated with tumor stemness in the immune microenvironment of T-cell exhaustion for hepatocellular carcinoma.
Zhang G
Discover oncology 2023 Nov 13;14(1):203
Discover oncology 2023 Nov 13;14(1):203
Increased PAFAH1B3 was associated with poor prognosis and T-cell exhaustion microenvironment in hepatocellular carcinoma.
Zhang G
Discover oncology 2023 Dec 8;14(1):227
Discover oncology 2023 Dec 8;14(1):227
Aberrant expression of PAFAH1B3 associates with poor prognosis and affects proliferation and aggressiveness in hypopharyngeal squamous cell carcinoma.
Xu J, Zang Y, Cao S, Lei D, Pan X
OncoTargets and therapy 2019;12:2799-2808
OncoTargets and therapy 2019;12:2799-2808
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- human brain tissue were subjected to SDS PAGE followed by western blot with 20564-1-AP(PAFAH1B3 antibody) at dilution of 1:500
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human spleen using 20564-1-AP(PAFAH1B3 antibody) at dilution of 1:50 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The PAFAH1B3 antibody from Proteintech is a rabbit polyclonal antibody to a peptide of human PAFAH1B3. This antibody recognizes human,mouse,rat antigen. The PAFAH1B3 antibody has been validated for the following applications: ELISA, WB, IHC analysis.
